Docoh
Loading...

276 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
PRPO Precipio Inc
12 Nov 21
Quarterly report
4:02pm
as both the cost of equipment and the cost of the diagnostic reagents are prohibitive. By utilizing our HSRR program, the customer can generate … reference laboratories. The HSRR customer also benefits from obtaining faster results, thus ultimately providing better patient care. During the first
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
our HSRR program, the customer can generate in-house testing revenues through reagent purchase contracts and economical lease-to-own rates instead … of sending out the same tests to large commercial reference laboratories. The HSRR customer also benefits from obtaining faster results, thus ultimately
8-K
EX-99.1
PRPO Precipio Inc
28 Jul 21
Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
4:41pm
. Customers who sign up for the HemeScreen POL program enter into a 4-year commitment. As we expand our panel offering, each POL customer can generate … increasing recurring revenues for Precipio. Simply stated, each new customer contract adds another building block to a solid and growing customer base
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
are referenced out as both the cost of equipment and the cost of the diagnostic reagents are prohibitive. By utilizing our HSRR program, the customer can … commercial reference laboratories. The HSRR customer also benefits from obtaining faster results, thus ultimately providing better patient care. During
DEF 14A
PRPO Precipio Inc
29 Apr 21
Definitive proxy
4:31pm
, operating efficiency, customer satisfaction, working capital, earnings (loss) per share of Stock, sales or market shares and number of customers, any
424B5
brv ntv1vw
2 Apr 21
Prospectus supplement for primary offering
2:00pm
10-K
z4mbl
29 Mar 21
Annual report
4:29pm
10-Q
78zm 8i4pakchmr
13 Nov 20
Quarterly report
4:01pm
10-Q
7cxttiq6b6u0z
13 Aug 20
Quarterly report
3:07pm
8-K
EX-99.1
df5bntw4a87ck
22 Jul 20
Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20
4:00pm
424B3
t5mgyz431ahoy
7 Jul 20
Prospectus supplement
5:27pm
S-1
qo1be 5j6mbzq34nrp
26 Jun 20
IPO registration
5:18pm
10-Q
tprxzu1ye
14 May 20
Quarterly report
4:05pm
DEF 14A
iziczm3
29 Apr 20
Definitive proxy
4:32pm
424B3
9w4luz4doxlfx
13 Apr 20
Prospectus supplement
4:55pm
S-3/A
eqq2yrpg4
9 Apr 20
Shelf registration (amended)
1:53pm
S-1/A
6zoba2 4izb6
8 Apr 20
IPO registration (amended)
3:41pm
S-3
05a7lns 6l6l
27 Mar 20
Shelf registration
4:51pm
S-1
tlr3slg5mgz1h2m99y2
27 Mar 20
IPO registration
4:31pm
10-K
2jo1h2osk67kjyytv4ou
27 Mar 20
Annual report
3:47pm